Malignant hyperthermia: current trends in treatment.
D000138:Acidosis / Q000188:drug therapy; D001639:Bicarbonates / Q000627:therapeutic use; D004796:Clinical Enzyme Tests; D003402:Creatine Kinase / Q000097:blood; D003452:Cryosurgery; D006801:Humans; D006947:Hyperkalemia / Q000628:therapy; D008305:Malignant Hyperthermia / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics / Q000517:prevention & control / Q000628:therapy*; D009127:Muscle Rigidity / Q000188:drug therapy; D009139:Musculoskeletal Abnormalities; D009211:Myoglobin / Q000097:blood; D011342:Procainamide / Q000008:administration & dosage / Q000627:therapeutic use; D013390:Succinylcholine / Q000009:adverse effects; D013925:Thromboplastin
D001639:Bicarbonates; D009211:Myoglobin; D013925:Thromboplastin; D003402:Creatine Kinase; D013390:Succinylcholine; D011342:Procainamide